procyanidin has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Yu, H; Zhao, J; Zheng, Y; Zhu, J | 1 |
| Chaurasiya, ND; Joshi, VC; Khan, IA; Khan, SI; Miller, LS; Muhammad, I; Rahman, MM; Samoylenko, V; Tekwani, BL; Tripathi, LM; Wang, YH; Wigger, FT | 1 |
| Guo, XH; Han, YY; Li, HF; Ruan, WL; Shen, SH; Xu, Y; Xu, YL; Zhang, H; Zhao, MN | 1 |
| Chen, H; He, P; Jiao, J; Li, S; Liu, C; Lv, Y; Mao, X; Xu, J; Xue, X | 1 |
| Ferruzzi, MG; Grace, MH; Lila, MA; Rochet, JC; Roy, SL; Simon, JE; Strathearn, KE; Tambe, MA; Wu, QL; Yousef, GG | 1 |
5 other study(ies) available for procyanidin and Parkinson Disease
| Article | Year |
|---|---|
The Relationship between Procyanidin Structure and Their Protective Effect in a Parkinson's Disease Model.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biflavonoids; Catechin; Oxidative Stress; Parkinson Disease; Proanthocyanidins; Rats; Selegiline; Zebrafish | 2022 |
Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
Topics: Alkaloids; Animals; Banisteriopsis; Beverages; Biflavonoids; Catechin; Ethnopharmacology; Harmaline; Harmine; Humans; Monoamine Oxidase; Neurodegenerative Diseases; Parkinson Disease; Plant Leaves; Plant Stems; Plants; Proanthocyanidins; Reference Standards; Superoxide Dismutase | 2010 |
[Improvement effect of proanthocyanidins on cell viability of rotenone-induced Parkinson's disease model].
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Humans; Neuroprotective Agents; Parkinson Disease; Proanthocyanidins; Reactive Oxygen Species; Rotenone | 2020 |
Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson's disease models in vitro and in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cell Proliferation; Cell Survival; Disease Models, Animal; Dopaminergic Neurons; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PC12 Cells; Proanthocyanidins; Rats; Reactive Oxygen Species; Signal Transduction | 2018 |
Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.
Topics: Animals; Anthocyanins; Cells, Cultured; Dopaminergic Neurons; Mice; Microglia; Mitochondria; Neuroprotective Agents; Parkinson Disease; Phytotherapy; Plant Extracts; Proanthocyanidins; Rotenone; Tyrosine 3-Monooxygenase | 2014 |